 |
|
|
| |
Immunological Comparison of Viral Control in the RIO Trial Versus HIV Elite Controllers
|
| |
| |
IAS 2026 Rio, Brazil
C. Nel*, T. Tipoe, J. Edgar, P. Zacharopoulou, M. Lee, L.-R. Cherrill, E. Falaschetti, H. Box, T. Elliott, S. Kinloch, J. Fox, A. Clarke, S. Pett, S. Collins, M.B.
Balachandran, K. Topping, L. Terry, K. Seaton, G. Tomaras, A. Uriel, C. Orkin, G. Whitlock, M. Boffito, R. Sutherland, H. Brown, N. Robinson, P. Goulder, M. Caskey, M. Nussenzweig, S. Fidler, J. Frater, The RIO Study Team
University of Oxford, UK; Chinese University of Hong Kong, Hong Kong SAR, China; Imperial College London, UK; Imperial NIHR Biomedical Research Centre, UK; Royal Free London NHS Foundation Trust, UK; Guy's and St Thomas' NHS Foundation Trust, UK; Brighton & Sussex Medical School, UK; University College London & Central and Northwest London NHS Foundation Trust, UK; HIV i-Base, UK; Duke University, USA; Manchester University NHS Foundation Trust, UK; Queen Mary University of London & Barts Health NHS Trust, UK; Chelsea and Westminster Hospital, UK; Western General Hospital, UK; Rockefeller University, USA; Howard Hughes Medical Institute, USA; Oxford NIHR Biomedical Research Centre, UK
|
| |
|
|
|
|
|
